Company Data
REGENXBIO Inc.
Ticker
RGNX
Current Price
$6.52 -8.68%
Market Cap
$337.1M
Price Target
Refer to Report
Volume
1.3M
52wk Range
$5.455 - $16.19
Overview
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno-associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa).